How COVID-19 Pandemic is Accelerating Modern Medicine

As businesses, patients, healthcare providers and government find a collective way forward in a post-COVID world, we’re all witnessing an accelerated transformation of modern healthcare. 

This esteemed panel of public and private industry experts will uncover new avenues for health access with the surge of telemedicine adoption  -as providers see more patients remotely to mitigate the risk of transmission-  from the design of mobile testing technologies now deployed to expand point of care testing options to the FDA’s approach to bringing coronavirus prevention and treatments to market as fast as possible. It's clear that the dynamic nature of this black swan event demands a comprehensive and collaborative market response. 

This program will provide critical insights and market perspectives to help us navigate this rapid industry growth while shining a light on the innovative hopes that reflect the fact that we’re in this together and we’ll get through this together.

Opening Remarks: Eric Dube, PhD | President & CEO, Retrophin

PANELISTS

Ann Mond Johnson | CEO, American Telemedicine Association

Marsha Henderson | Former FDA Associate Commissioner

Katherine Atkinson | Chief Commercial Officer Truvian

Moderator | Dr. Anita Gupta | SVP Medical Strategy, Heron Therapeutics